HomeInsightsStock Comparison

Astonea Labs Ltd vs Senores Pharmaceuticals Ltd Stock Comparison

Astonea Labs Ltd vs Senores Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jul 22, 2025

Key Highlights

  • The Latest Trading Price of Astonea Labs Ltd is ₹ 181.85 as of 22 Jul 15:30.
  • The P/E Ratio of Astonea Labs Ltd is 0 as of March 2022 .The P/E Ratio of Senores Pharmaceuticals Ltd is 0 as of March 2022.
  • The Market Cap of Astonea Labs Ltd is ₹ 0 crore as of March 2022 .The Market Cap of Senores Pharmaceuticals Ltd is ₹ 0 crore as of March 2022.
  • The revenue of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Senores Pharmaceuticals Ltd for the Mar '25 is ₹ 125.98 crore as compare to the Dec '24 revenue of ₹ 108.18 crore. This represent the growth of 16.45%.
  • The ebitda of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Senores Pharmaceuticals Ltd for the Mar '25 is ₹ 31.21 crore as compare to the Dec '24 ebitda of ₹ 30.85 crore. This represent the growth of 1.17%.
  • The net profit of Astonea Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of 0.0% The net profit of Senores Pharmaceuticals Ltd changed from ₹ 7.11 crore to ₹ 17.97 crore over 4 quarters. This represents a CAGR of 152.74% .
  • The Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2021 to 0 % on March 2024 . This represents a CAGR of 0.0% over 4 yearsThe Dividend Payout of Senores Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2024 . This represents a CAGR of 0.0% over 4 years.

Share Price

* All values are in Rupees

PE

Market Cap

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astonea Labs Ltd

  • Astonea Labs Ltd was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
  • Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
  • Subsequently, the Company converted into 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
  • These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
  • These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

About Senores Pharmaceuticals Ltd

  • Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
  • Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company. Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms.
  • The Regulated Markets business is focused on Regulated Markets of US and Canada.
  • The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs.

Astonea Labs Ltd News Hub

News

Astonea Labs announces board meeting date

Astonea Labs will hold a meeting of the Board of Directors of the Company on 11 July 2025....

Read more

05 Jul 2025 11:04

News

BSE SME Astonea Labs inches higher on debut

The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public off...

Read more

03 Jun 2025 11:01

Senores Pharmaceuticals Ltd News Hub

News

Senores Pharmaceuticals to discuss results

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23...

Read more

17 Jul 2025 16:11

News

Senores Pharmaceuticals to hold board meeting

Senores Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 15...

Read more

10 May 2025 11:12

News

Senores Pharmaceuticals Inc. to acquire USFDA approved ANDA for Tramadol Tablets

Senores Pharmaceuticals (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals...

Read more

09 May 2025 09:29

News

Senores Pharmaceuticals gains on acquiring Topiramate tablets from Wockhardt

Shares of Wockhardt declined 2.15% to Rs 1,267 on the BSE. The market size of Topiramate t...

Read more

06 May 2025 10:51

News

Senores inks deal to acquire Wockhardt's ANDA for Topiramate

Senores Pharmaceuticals (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals...

Read more

05 May 2025 18:55

News

Senores Pharmaceuticals to acquire 14 ANDAs from Dr Reddy's

Senores Pharmaceuticals (SPL), through its wholly-owned subsidiary Senores Pharmaceuticals...

Read more

04 Mar 2025 14:23

FAQs for the comparison of Astonea Labs Ltd and Senores Pharmaceuticals Ltd

Which company has a larger market capitalization, Astonea Labs Ltd or Senores Pharmaceuticals Ltd?

Market cap of Astonea Labs Ltd is 191 Cr while Market cap of Senores Pharmaceuticals Ltd is 2,838 Cr

What are the key factors driving the stock performance of Astonea Labs Ltd and Senores Pharmaceuticals Ltd?

The stock performance of Astonea Labs Ltd and Senores Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astonea Labs Ltd and Senores Pharmaceuticals Ltd?

As of July 22, 2025, the Astonea Labs Ltd stock price is INR ₹181.85. On the other hand, Senores Pharmaceuticals Ltd stock price is INR ₹616.35.

How do dividend payouts of Astonea Labs Ltd and Senores Pharmaceuticals Ltd compare?

To compare the dividend payouts of Astonea Labs Ltd and Senores Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions